Wunderhorse frontman Jacob Slater talks about 'Midas' and how he feels about those comparisons to Radiohead and Nirvana ...
With Takeda’s £46 billion acquisition of Shire, it’s been a busy year for pharma M&A – and according to analysts Datamonitor, the specialist biotechs Nektar, BioMarin and Alnylam are the ...
PT101 is an engineered IL-2 mutein fused to a protein backbone, and is vying to come to market along with other IL-2-based therapies, notably Eli Lilly and Nektar Therapeutics’ phase 2 candidate ...
After hours: March 21 at 6:34:29 PM EDT Loading Chart for NKTR ...
After hours: March 21 at 6:12:04 PM EDT Loading Chart for BAND ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results